CDChun-Shan Dong

Chun-Shan Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chun-Shan Dong has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Ying Huang

    Department of Anesthesiology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

    4 shared publications
  • Jun Wang

    Department of Anesthesiology, Anhui Medical University Third Affiliated Hospital (Hefei First People’s Hospital), Hefei, Anhui, People’s Republic of China

    3 shared publications
  • Lang Liu

    Department of Anesthesiology, Anhui Medical University Third Affiliated Hospital (Hefei First People’s Hospital), Hefei, Anhui, People’s Republic of China

    3 shared publications
  • Qiang Lu

    Department of Anaesthesiology, Anhui Medical University Third Affiliated Hospital (Hefei First People’s Hospital), Hefei, Anhui, People’s Republic of China

    3 shared publications
  • Hai-Feng Bao

    Department of Anaesthesiology, Anhui Medical University Third Affiliated Hospital (Hefei First People’s Hospital), Hefei, Anhui, People’s Republic of China

    2 shared publications
  • Yao Lu

    Department of Anaesthesiology, Anhui Medical University First Affiliated Hospital, Hefei, Anhui, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Effect of Pericapsular Nerve Group Block with Wound Infiltration vs Modified Supra-Inguinal Fascia Iliaca Block on Postoperative Analgesia in Adult Patients Undergoing Total Hip Arthroplasty – A Randomized Clinical Trial

    by Ying Huang, Sheng Peng, Jun Wang, Lang Liu, Chun-Shan Dong

    Purpose: Pericapsular nerve group (PENG) block and supra-inguinal fascia iliaca block (S-FICB) provides incomplete analgesia for total hip arthroplasty (THA) due to anatomical limitations. This study compares two modified approaches—PENG block with wound infiltration (WI) and a modified S-FICB—to identify the optimal analgesic technique for THA. Patients and Methods: Eighty-six subjects were randomly allocated to either the PENG block + WI group or the modified S-FICB group. The primary outcome was the postoperative numeric rating scale (NRS) pain scores (rest/hip adduction) at 6 hours. The secondary outcomes were pain scores at 12, 24, 48 hours postoperatively and postoperative day 5, the incidence of postoperative quadriceps motor block at 6, 12, 24, 48 hours and postoperative day 5, the mean blood pressure (MAP) at five time points, patient-controlled intravenous analgesia (PCIA) usage and adverse effects such as the incidence of rescue analgesia, local anesthetic systemic toxicity (LAST), postoperative hip infection, the incidence of postoperative nausea and vomiting (PONV) within 5 days after surgery. Results: PENG + WI group had lower NRS at rest (6h) (95% CI 0.51– 1.64, p< 0.001). Compared with the PENG block + WI, the modified S-FICB resulted in a higher incidence of quadriceps motor block at 6 hours (82.1% vs 25.6%; OR=13.257, 95% CI 4.46– 39.38; p< 0.001) and 12 hours (71.8% vs 41%; OR=3.659, 95% CI 1.42– 9.42; p=0.001). Conclusion: PENG block + WI provides sufficient postoperative analgesia with no quadriceps motor block compared to modified S-FICB, supporting early ambulation and in line with the enhanced recovery after surgery (ERAS) protocols.


  • Open Access

    Effect of Pericapsular Nerve Group Block with Different Concentrations and Volumes of Ropivacaine on Functional Recovery in Total Hip Arthroplasty: A Randomized, Observer-Masked, Controlled Trial [Response to Letter]

    by Ying Huang, Chun-Shan Dong

    Response to Letter in regards to Effect of Pericapsular Nerve Group Block with Different Concentrations and Volumes of Ropivacaine on Functional Recovery in Total Hip Arthroplasty: A Randomized, Observer-Masked, Controlled Trial [Letter]

  • Open Access

    Effect of Pericapsular Nerve Group Block with Different Concentrations and Volumes of Ropivacaine on Functional Recovery in Total Hip Arthroplasty: A Randomized, Observer-Masked, Controlled Trial

    by Ying Huang, Yao Lu, Jun Wang, Qiang Lu, Hai-Feng Bao, Lang Liu, Chun-Shan Dong

    Purpose: The pericapsular nerve group (PENG) block provides satisfactory postoperative analgesia without hampering motor function for total hip arthroplasty (THA); however, unexpected motor block has been observed clinically. It is unknown whether this motor block is related to the dose of ropivacaine. We aimed to conduct a prospective randomized trial to test whether reducing the volume or concentration of ropivacaine was better for less motor block after PENG block. Patients and Methods: Ninety-nine patients with fracture or femoral head necrosis scheduled for THA were randomly allocated to receive 20 mL 0.5% ropivacaine (Group A), 20 mL 0.25% ropivacaine (Group B), and 10 mL 0.5% ropivacaine (Group C). The primary outcome was the incidence of postoperative quadriceps motor block at 6 hours. Secondary outcomes were the incidence of postoperative quadriceps motor block at 0, 12, 24 and 48 hours; pain scores on the numeric rating scale (NRS) at all postoperative time points (0, 6, 12, 24, and 48 hours); the time to first walk; the incidence of rescue analgesia; side effects such as dizziness, ache, nausea, and vomiting; and patient satisfaction. Results: Compared with Group A, Group C resulted in a lower incidence of quadriceps motor block at 0 hours, 6 hours and 12 hours postoperatively (P < 0.05), while Group B only resulted in a lower incidence of motor block at 12 hours postoperatively (P < 0.05). No intergroup differences were found in terms of postoperative pain scores, the incidence of rescue analgesia, adverse events or patient satisfaction (P > 0.05). Conclusion: A higher incidence of motor blockade was observed when 20 mL of 0.5% ropivacaine was administered, which was mainly caused by the excessive volume. Therefore, we recommend performing PENG block with 10 mL 0.5% ropivacaine.


  • Open Access

    Impact of ropivacaine volume and concentration on functional recovery following surgical treatment of hip fractures: a randomized, observer-masked, controlled trial

    by Ying Huang, Chun-Shan Dong, Yao Lu, Jun Wang, Qiang Lu, Hai-Feng Bao, Lang Liu

    Background: The pericapsular nerve group (PENG) block is a novel regional anaesthesia technique aiming to provide better hip analgesia without hampering motor function . However, the factor of pain on muscle strength cannot be ruled out and unexpected motor block has still been observed clinically. So it is unknown whether the motor-reservation is partly due to the effect of pain reduction and it is unknown whether this unexpected motor block is caused by the inappropriate dose of ropivacaine.Methods: We investigated the ropivacaine volume and concentration effect on muscle strength and analgesia. With ethical committee approval, 90 consenting patients undergoing surgical treatment of hip fractures were randomly allocated to receive one of three volume/concentration combinations of ropivacaine (20 ml/0.5%, 20 ml/0.25% and 10 ml/0.5%). The primary outcome measure was postoperative quadriceps strength using the knee extension test and Oxford muscle strength grading 12, with grouped scores of intact (5/5), reduced (1-4/5) and absent (0/5) measured at 6 and 12 hours postoperatively. Secondary outcomes included postoperative pain scores (0-10 numeric rating scale), blood pressure, patient movement assessments, patient satisfaction and side effects.Results: Overall, 10 ml of 0.5% ropivacaine resulted in a lower incidence of quadriceps motor block at 6 hours (76.7% vs. 40.0% vs. 46.7%; pConclusions: As for the PENG block, the effect of pain on muscle strength can be ruled out. Unexpected motor block of PENG block may be caused by inappropriate dose of ropivacaine. We found that 10 ml 0.5% ropivacaine resulted in better muscle strength, considering the significance of rapid rehabilitation, we recommend performing PENG block with 10 ml 0.5%Trial registration: ChiCTR2100052511 . Register Date 2021/10/30

  • Open Access

    The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus

    by Qiang Lu, Chun-Shan Dong, Jun-Ma Yu, Hao Sun, Peng Sun, Xiang Ma, Chun Luo

    Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED50) and 95% effective dose (ED95) of epidural sufentanil as an adjuvant combination with local anesthetics for relief visceral pain in parturients with scarred uterus undergoing elective cesarean section. One hundred parturients with scarred uterus undergoing elective cesarean section under epidural anesthesia were enrolled in this randomized, double-blinded, dose-ranging study. Parturients received 5, 10, 15, 20, and 25 μg epidural sufentanil as an adjuvant with 10 mL of 0.65% ropivacaine. Successful epidural anesthesia was defined as a sixth thoracic vertebra (T6) sensory level achieved within 20 minutes after epidural drugs administration and/or no visceral pain by traction on the abdominal viscera during the cesarean section. The ED50 and ED95 were calculated with a logistic regression model. ED50 and ED95 of epidural sufentanil for successful of the pain-free from visceral pain were 10.7 μg [95% confidence interval (CI): 2.4–14.4 μg) and 28.1 μg (95% CI: 19.4–44.0 μg), respectively. The onset time to sensory block, maximum Bromage scale and duration of motor block were significant different with dose of sufentanil >20 μg (P < .05, compared with the other dose groups). With the dose of epidural sufentanil >20 μg could result in an increase of incidence of maternals’ adverse effects. Compared with a different dose of sufentanil, epidural administed sufentanil between 15 μg and 20 μg can maximize parturients’ satisfaction. Our study showed that sufentanil could be used in combination with ropivacaine for relief from somato-visceral pain in patients with scarred uterus during elective cesarean section during epidural anesthesia, and that maximized parturients’ satisfaction could be achieved when the use of sufentanil with the dose between 15 μg and 20 μg for epidural anesthesia.


  • Open Access

    Effect of Dexmedetomidine combined with sufentanil for post- thoracotomy intravenous analgesia:a randomized, controlled clinical study

    by Chun-Shan Dong, Jun Zhang, Qiang Lu, Peng Sun, Jun-Ma Yu, Chao Wu, Hao Sun

    Few studies have investigated the use of dexmedetomidine in patient-controlled intravenous analgesia (PCIA) after thoracic surgery. This study to evaluate the effect of dexmedetomidine combined with sufentanil for PCIA after thoracotomy under general anaesthesia. Ninety-seven adults patients scheduled for thoracotomy surgery. All two groups received PCIA with either sufentanil alone (control group) or combining dexmedetomidine with sufentanil (dexmedetomidine group). Hemodynamic measurements, visual analog scale (VAS) scores at rest and at coughing, Ramsay sedation score (RSS), analgesic consumption, and postoperative nausea and vomiting (PONV) as well as drug-related adverse effects were compared at 2, 6, 12, 24, 36 and 48 h postoperatively. In the patients of the dexmedetomidine group, compared to the control group, the pain scores at rest or at coughing during 48 h postoperatively were lower (P < 0.001), the sedation scores were lower, the consumption of sufentanil and rescue meperidine were lower, and the number of episode of moderate PONV was three times lower. No signs of toxicity or local complications were observed. There was a non-significant trend for a lower HR and BP in the dexmedetomidine group vs. Control. The combining dexmedetomidine with sufentanil for post-thoracotomy PCIA can improve pain control together with the decrease in sufentanil requirements, and improve postoperative patient’s satisfaction compared with sufentanil alone in PCIA. This trial was retrospectively registered on 27 April 2016 at the Chinese Clinical Trial Register (number: ChiCTR-ONC-16008376 ).